Welcome to our Blog!
Dr. Christian Steiner,
Managing Director CytoSorbents Europe
I welcome you to our official CytoSorbents Blog “Let’s talk…”and I want to personally invite you to discuss and exchange opinions via this platform.
CytoSorbents’ adsorption technology represents a new category of blood purification. Because these new tools have to be used adequately to help patients in different situations, there is a need for continuous development and knowledge generation. Discussions, explanations, brainstorming and interaction in general can catalyze and accelerate this process. We will come up with interesting topics, new – also controversial – publications, hypotheses, and food for thoughts to inspire and stimulate dialogue.
So, I want to invite all users of our products, interested health care professionals, researchers, thinkers, supporters, and especially critics to actively discuss and share your opinion on relevant topics to progress with the development of patient-centric precision therapy schemes.
I thank you in anticipation.
Christian
Newest Blogpost
CytoSorb’s important role in severe rhabdomyolysis requiring continuous veno-venous haemodialysis
More from the CytoSorbents' Blog
CytoSorb’s important role in severe rhabdomyolysis requiring continuous veno-venous haemodialysis
Dr Volker Humbert on: Rapid and effective elimination of myoglobin with CytoSorb® hemoadsorber in patients with severe rhabdomyolysis.
Unveiling the Impact of CytoSorb Therapy on Fluid Balance in Septic Shock Patients
Unveiling the Impact of CytoSorb Therapy on Fluid Balance in Septic Shock Patients Dr Jörg Scheier on: “Impact of CytoSorb Hemoadsorption Therapy on Fluid Balance in Patients with Septic Shock” Kogelmann K, Hübner T, Drüner M, Jarczak D.Journal of Clinical
Improving Heart Transplant Outcomes: The Role of CytoSorb
Get to know more about Nemeth et al. report the results of a single site study of 60 patients undergoing heart transplantation, randomised to receive CytoSorb.
1 Comment
hi -very interesting 🙂